Paradigm

Paradigm is growing and we continue to impact cancer care today, by creating more equitable and systemic access to therapeutic clinical trials. We are currently hiring for an exciting addition to our team for an Executive Medical Director with an oncology background to work collaboratively across the company to support our vision to create a new clinical trial paradigm. We are looking for an innovative physician/researcher who not only excels in current treatment paradigms but has a passion for data and medical informatics and is looking break the status quo and help us build a new future for clinical trials. If you are interested in joining me and our phenomenal team please reach out and apply via the link or the posting below - https://lnkd.in/gTxU7ajx. If you know of candidates that you think would be a great fit and want to refer - please reach out to me!

As a rural health system, our patients deserve the best care close to home. We are excited to partner with Paradigm to get our patients the care they deserve. 💚   "Patients in rural communities face geographic and socioeconomic burdens that inhibit access to novel treatments. It is imperative that we expand patient access to research through community health systems," said Altru Research Program Manager Ashlee Dagoberg, PT, DPT.”

As we celebrate Pride Month 2024, this video always makes me smile. The pure JOY and PRIDE I feel as a member of the LGBTQ+ community is clear, and the song carries such a critical message! As an OUT LGBTQ+ CEO/Founder, I understand the importance of visibility for LGBTQ+ employees and the community as a whole. Sadly, the current political landscape in the United States is filled with fear and hate, with numerous anti-LGBTQ+ laws being passed in most states. The potential rollback of existing LGBTQ+ protections is concerning, especially with the continuous discriminatory laws targeting transgender individuals, leading to increased violence and hate crimes. It's crucial for companies and leaders like me to use our voices to protect LGBTQ+ employees and advocate for equality. Providing a safe and supportive environment for all employees to thrive and be their authentic selves is essential. Having healthcare benefits that offer access to gender-affirming care and LGBTQ+ affirming policies will make a positive impact on workplace inclusivity. What have you done today to make yourself PROUD? Every voice matters—let's use ours to fight for equality and ensure every member of the LGBTQ+ community can live proudly and safely, feeling included and valued at work. #pridemonth2024 #equality #lgbtqia #healthcareequity #transrightsarehumanrights #lgbtqrights

Ensuring clinical trial access is more equitable and available for all patients has been our mission since we founded Paradigm.    For the rural and community patients, clinical trial access is an imperative .   In the rural communities stretching across North Dakota and Minnesota, accessing oncology #clinicaltrials can be challenging. Paradigm partnered with Altru Health System to increase clinical trial participation across their 225k patients in rural North Dakota and Minnesota. We’re thrilled to be able to share that this collaboration increased patient participation in clinical trials from 4% to 11% of the total cancer population, well above the national average for oncology programs, across Altru’s massive rural service area in North Dakota and Minnesota. This means that more patients received access to interventional clinical trials as part of their routine care. This was accomplished by increasing pre-screening and simplifying the enrollment process, while simultaneously reducing Altru staff burden through effective use of the Paradigm platform and clinical services. A step-change in clinical trial participation acts as both an equalizer between rural and urban care, and an accelerating force for the broader research and development ecosystem, ultimately increasing the potential for more patients to benefit from new trials today and accelerating bringing new treatments to market. We’re grateful for Altru’s partnership in this effort and proud to serve their patient community. If you’d like to learn more about working with Paradigm please reach out! https://lnkd.in/gnr8s2yP

Paradigm is building a new model for #clinicaltrials, from the ground up, using technology to scale access. Recently, we worked with OpenAI to evaluate GPT-4 to reduce the administrative burden of screening patients for clinical trials. Our team achieved amazing results, exceeding accuracy of industry best practice while dramatically decreasing the time to read, extract, and interpret medical record data. By incorporating LLMs into Paradigm’s platform, we can screen every patient faster, more accurately, and at a dramatically lower cost, helping create equitable access for any patient, anywhere. We are excited that OpenAI shared our results here: https://lnkd.in/eE5MYUzw

We’re welcoming Kelly Haenlein to Paradigm today, where she’s taking on the newly created role of VP, Commercial Business. Paradigm’s mission is to create equitable access to clinical trials for any patient, anywhere and Kelly’s experience is perfectly matched to support that effort. In her previous role, she saw first-hand how the logistics of the clinical trial ecosystem and lack of access for so many patients can slow development of promising new therapeutics. We couldn’t be happier to have Kelly join us at Paradigm and we’re excited for her contributions.

We’re welcoming Kelly Haenlein to Paradigm today, where she’s taking on the newly created role of VP, Commercial Business. Paradigm’s mission is to create equitable access to clinical trials for any patient, anywhere and Kelly’s experience is perfectly matched to support that effort. In her previous role, she saw first-hand how the logistics of the clinical trial ecosystem and lack of access for so many patients can slow development of promising new therapeutics. We couldn’t be happier to have Kelly join us at Paradigm and we’re excited for her contributions.

We're proud to see our portfolio company, Paradigm, collaborating with Bristol Myers Squibb to redefine clinical trials with a new patient-centric model. Congratulations to Kent Thoelke 🏳️🌈 and the entire team on this momentous move toward Health Assurance! Explore the future of equitable clinical trials ↓

At Paradigm, we're creating a new patient-centric model for clinical trials. When more patients have the option to participate, we can achieve better care and help bring new treatments to market faster. Today we’re announcing a new collaboration with Bristol Myers Squibb: to build a new end-to-end model for clinical trials, starting in oncology. Our two organizations share a commitment to bring access to clinical trials to underserved populations and reduce the burden of trials on patients and providers – which will speed both recruitment and results. #BristolMyersSquibb #BMS Read more in our press release here --> https://lnkd.in/g4kDd8zC

At Paradigm, we're creating a new patient-centric model for clinical trials. When more patients have the option to participate, we can achieve better care and help bring new treatments to market faster. Today we’re announcing a new collaboration with Bristol Myers Squibb: to build a new end-to-end model for clinical trials, starting in oncology. Our two organizations share a commitment to bring access to clinical trials to underserved populations and reduce the burden of trials on patients and providers – which will speed both recruitment and results.  Read more in our press release here --->https://lnkd.in/g4kDd8zC